FT. LEE, N.J.--(BUSINESS WIRE)--
Association, the non-profit collaboration that developed and manages the
global SAFE-BioPharma® digital identity and digital signature standard,
has elected James W. Brown, Ph.D., Chief Operating Officer, REGENX
Biosciences, to its Board of Directors.
standard is used throughout the biopharmaceutical and healthcare
industries to manage digital identity trust and to apply legally binding
digital signatures to electronic documents. It is a strategic initiative
of the life sciences industry to facilitate secure, trusted and fully
electronic business and regulatory processes. The association’s members
include most of the world’s largest biopharmaceutical companies.
Based in Washington, D.C., REGENX is a personalized gene therapy company
focused on unmet needs of a variety of severe diseases. Before joining
REGENX, Dr. Brown was responsible for IT strategy and project portfolio
for R&D at MedImmune. He also served in a variety of IT leadership roles
in other life science companies. Earlier in his career, Dr. Brown was a
National Research Council Postdoctoral Fellow at the National Institutes
of Standards and Technology (NIST). He received his Ph.D. in Biophysical
Chemistry from Stanford University and a B.S. in chemistry from Butler
SAFE-BioPharma Association has an all-volunteer Board which determines
the association's strategic direction and business model, and oversees
its management. Among numerous recent initiatives are global expansion
of the standard through integration with biopharmaceutical and
healthcare industry applications such as signing engines, portal
providers, clinical trial applications, ePrescribing, access to eHRs,
and other critical digital workflows.
“We welcome James Brown and his extensive R&D information technology
experience. He will be an important asset to the future of
SAFE-BioPharma," said Mollie Shields-Uehling, president and CEO and a
director of SAFE-BioPharma Association.
For more information on the SAFE-BioPharma standard for digital identity
and digital signatures used in life science and healthcare settings,
SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Any use of
this trademark requires approval from SAFE-BioPharma Association.
Jon Weisberg, 801-359-9977
Source: SAFE-BioPharma Association